| May 23, 2025 |
May 28, 2025 |
LyondellBasell Industries N.V.
|
Director |
Sell |
46.3
|
-314
|
-2.59%
|
✗
|
$17.6K |
| Sep 30, 2024 |
Oct 2, 2024 |
LyondellBasell Industries N.V.
|
Director |
Sell |
82.5
|
+386
|
4.59%
|
✗
|
$8.2K |
| May 18, 2024 |
May 21, 2024 |
LyondellBasell Industries N.V.
|
Director |
Sell |
46.3
|
-305
|
-4.57%
|
✗
|
$30.8K |
| Mar 31, 2024 |
Apr 2, 2024 |
LyondellBasell Industries N.V.
|
Director |
Sell |
85.0
|
+360
|
5.70%
|
✗
|
$5.1K |
| Jun 23, 2022 |
Jul 28, 2023 |
CULLEN/FROST BANKERS, INC.
|
Director |
Buy |
90.0
|
+1
|
100.00%
|
✗
|
$109 |
| Dec 10, 2021 |
Jul 10, 2023 |
LyondellBasell Industries N.V.
|
Director |
Buy |
47.5
|
+2
|
0.03%
|
✗
|
$255 |
| May 26, 2023 |
May 31, 2023 |
LyondellBasell Industries N.V.
|
Director |
Sell |
46.3
|
-264
|
-4.46%
|
✗
|
$23K |
| May 28, 2022 |
Jun 1, 2022 |
LyondellBasell Industries N.V.
|
Director |
Sell |
46.3
|
-97
|
-2.97%
|
✗
|
$11.4K |
| Nov 14, 2013 |
Nov 14, 2013 |
Sarepta Therapeutics, Inc.
|
Director |
Buy |
95.0
|
+10,000
|
31.50%
|
✗
|
$139.5K |
| Aug 22, 2013 |
Aug 23, 2013 |
Sarepta Therapeutics, Inc.
|
Director |
Buy |
95.0
|
+3,500
|
12.39%
|
✗
|
$114.4K |
| Jun 14, 2013 |
Jun 18, 2013 |
Sarepta Therapeutics, Inc.
|
Director |
Buy |
97.5
|
+10,000
|
54.81%
|
✗
|
$385K |
| Nov 27, 2012 |
Nov 29, 2012 |
Sarepta Therapeutics, Inc.
|
Director |
Sell |
20.0
|
-10,000
|
-36.71%
|
✗
|
$294.6K |
| Nov 14, 2012 |
Nov 15, 2012 |
Sarepta Therapeutics, Inc.
|
Director |
Sell |
20.0
|
-10,000
|
-26.85%
|
✗
|
$257K |
| Sep 7, 2012 |
Sep 11, 2012 |
Sarepta Therapeutics, Inc.
|
Director |
Sell |
20.0
|
-33,000
|
-46.98%
|
✗
|
$477K |
| Sep 13, 2011 |
Sep 14, 2011 |
Sarepta Therapeutics, Inc.
|
Director |
Buy |
86.3
|
+20,000
|
5.04%
|
✗
|
$24K |
| Jun 9, 2010 |
Jun 10, 2010 |
Sarepta Therapeutics, Inc.
|
Director |
Buy |
95.0
|
+46,500
|
13.48%
|
✗
|
$65.9K |
| May 21, 2010 |
May 24, 2010 |
Sarepta Therapeutics, Inc.
|
Director |
Buy |
95.0
|
+50,000
|
16.95%
|
✗
|
$66.5K |
| May 17, 2010 |
May 18, 2010 |
Sarepta Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+29,607
|
11.16%
|
✗
|
$42.1K |
| May 12, 2010 |
May 14, 2010 |
Sarepta Therapeutics, Inc.
|
Director |
Buy |
95.0
|
+96,000
|
56.68%
|
✗
|
$129.6K |